echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The declining export volume of medical dressing products industry urgently needs to be upgraded and developed

    The declining export volume of medical dressing products industry urgently needs to be upgraded and developed

    • Last Update: 2021-02-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, sponsored by the China Health Products Import and Export Chamber of Commerce (hereinafter referred to as the "Medical Insurance Chamber of Commerce"), the 2017 China (International) Medical Supplies Conference was held in Beijing, hosted by the Medical Dressing Branch of the China Medical Insurance Chamber of Commerce and The Steady Medical Supplies Co., Ltd.At the
    meeting, Li Jianquan, president of the China Medical Dressings Branch and president of Steady Medical, said: "In the past ten years, medical supplies, especially medical dressing products in the international market has maintained high growth, China's medical supplies enterprises will be a simple product to achieve world-class, in Europe, the United States and Japan and other developed countries market to high-quality quality. "
    reporter learned that medical dressings are sanitary materials medical supplies, in China's export trade has been accounted for a large proportion. At present, China's medical dressing exports have accounted for more than 20% of the world's total medical dressing exports, the top three export destination markets are Europe, North America, Asia.
    However, according to the Medical Insurance Chamber of Commerce's 2017 China Medical Device Trade Data Yearbook, China's medical dressing exports reached US$2,357 million in 2016, down 9.89 percent year-on-year.high-end dressing storage and development space
    it is known that the mid-1980s to the 1990s is the first and second stage of the growth of China's dressing industry. At the beginning of the 21st century, the industry developed into the third stage of deep processing and packaging production. Thanks to market dividends and demographic dividends, many enterprises began to transform and upgrade, from doing primary raw materials development to products, equipment, plant integrated design, more refined products, more extreme cost control, industrial development to the climax, the achievement of a number of leading enterprises such as steady, Omei, Zhende.
    In recent years, the price fluctuations of cotton raw materials for traditional medical dressings have had a great impact on production enterprises, in addition, China's medical dressing industry in the order pressure, enterprise capital, labor costs, environmental responsibility, risk control and other aspects are also facing more or less problems.
    "In fact, China's traditional export market demand tends to be saturated, domestic prices rise faster, labor, raw materials, freight costs increased accordingly, resulting in an increase in export trade quotations, has been the price-effective domestic medical dressings in the international market competitive advantage is weakening." "Furthermore, as a result of the gradual devaluation of the currency and the lower cost of labour and raw materials, the price advantage of South-East Asian countries has gradually emerged, taking over a certain market.
    , the global advanced wound care market is now about $7.2 billion, more than twice the size of the traditional product market, with a wide range of segments and faster growth, according to Kalorama. China's wound care market in 2016 market size of about 3.3 billion yuan, future growth will also rely on advanced wound care and negative pressure drainage two major areas driven.
    , Wang Ying, Director of Steady Medical, said: "Driven by the global aging, the number of operations and chronic trauma patients has been growing steadily, with diabetic foot ulcers, for example, the fastest growing chronic disease, with a compound growth rate of 5% in 2016-2021. In addition, factors such as the increase in home care and long-term care facilities also provide room for the development of the market for advanced wound care and high-end dressing care. "
    regrets that Acelity, Xerflower, Mernik and Converse currently account for more than 60% of the premium wound care market at Acelity, the world's leading foreign companies. Other competitors include more than 40 medical device and consumables companies, such as 3M, Herman, Belang and UGG, and Chinese companies are struggling to break the pattern.
    industry analysis, compared with traditional medical dressings, high technical barriers to high-end dressings, domestic enterprises lack of research and development capabilities, product types, specifications less become the main "bottleneck" of industrial upgrading. In addition, the restrictions on domestic hospital fees and other factors make China's high-end dressing development to a certain extent hindered.to upgrade product competitiveness
    Although the medical dressing manufacturing industry is facing complex situations and difficulties, but the international medical dressing market prospects, many experts are still optimistic. Medical insurance chamber of commerce professionals analysis that the current medical dressing market still has huge business opportunities.
    To this end, Aomei Medical President Cui Jinhai believes that in the medical dressing industry transformation, upgrading the road, enterprises can take export to domestic sales, foundry to brand, low-end to high-end, extensive turn fine, extended industrial chain development strategy, through strategic management, business model, products, processes and equipment and other aspects of continuous innovation, to reshape the fundamentals of the enterprise.Wang Ying said:
    The future development of Chinese enterprises should change the strategy, from the entire industrial chain layout, the domestic market and overseas markets, focusing on quality control at the same time, we must put breakthrough and innovation in the first place in enterprise development."
    To this, there is industry analysis, if domestic enterprises want to further seize the international market, we must abandon low value, homogenization, low price, no brand and other traditional shortcomings, long-term vision, adapt to the situation, make full use of national policy support, in improving the enterprise's own management system at the same time, proactive innovation, increase research and development investment, cultivate independent brands, enhance the competitiveness of products in the international market. (Medical Economics)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.